Cofactors in in vitro induction of apoptosis in HL60 cells by all-trans retinoic acid (ATRA)

被引:15
作者
Carpentier, Y
Mayer, P
Bobichon, H
Desoize, B
机构
[1] FAC PHARM REIMS,IFR53,EA2063,F-51096 REIMS,FRANCE
[2] LABS INST J GODINOT,F-51096 REIMS,FRANCE
关键词
apoptosis; all trans retinoic acid; ATRA; glucose;
D O I
10.1016/S0006-2952(97)00345-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to determine the culture conditions that could modulate the induction of apoptosis by all-trans retinoic acid (ATRA). Cell viability was evaluated by trypan blue test, differentiation by nitro blue tetrazolium test, and apoptosis by morphological analysis. ATRA induced apoptosis in HL60 cells only when more than 100,000 cells/ml were seeded, while differentiation was induced regardless of the seeded cell concentration. Reduction in the concentration of foetal calf serum or glutamine in the medium led to a weak increase in apoptosis. In contrast, a dramatic enhancement of apoptosis occurred when the culture medium was supplemented with glucose or when the culture pH was decreased. These characteristics were independent of the mechanism of action of ATRA, but the action of glucose could be of significance in diabetic patients. An exchange of supernatants after 3 days of culture showed that supernatants from control cultures seeded at high cell density were better apoptosis inducers than supernatants from cultures treated with ATRA, but seeded at low cell density. Factor(s) in this supernatant which induced apoptosis was (were) removed by ultrafiltration. In conclusion, our results showed that ATRA alone cannot induce apoptosis, but can do so in conjunction with cofactors. The depletion of some components of the medium and the appearance of secreted macromolecule(s) could be cofactor(s) in the induction of apoptosis. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 25 条
[1]  
AVIGNOLO C, 1995, INT J ONCOL, V7, P1213
[2]  
BARRY MA, 1993, CANCER RES, V53, P2349
[3]   HIGH-GLUCOSE-TRIGGERED APOPTOSIS IN CULTURED ENDOTHELIAL-CELLS [J].
BAUMGARTNERPARZER, SM ;
WAGNER, L ;
PETTERMANN, M ;
GRILLARI, J ;
GESSL, A ;
WALDHAUSL, W .
DIABETES, 1995, 44 (11) :1323-1327
[4]   INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID [J].
BREITMAN, TR ;
SELONICK, SE ;
COLLINS, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2936-2940
[5]  
BREITMAN TR, 1990, METHOD ENZYMOL, V190, P118
[6]  
BROWN G, 1994, LEUKEMIA, V8, P806
[7]  
Calabresse C, 1995, LEUKEMIA, V9, P2049
[8]   RETINOIC ACID THERAPY FOR PROMYELOCYTIC LEUKEMIA [J].
CHOMIENNE, C ;
BALLERINI, P ;
BALITRAND, N ;
AMAR, M ;
BERNARD, JF ;
BOIVIN, P ;
DANIEL, MT ;
BERGER, R ;
CASTAIGNE, S ;
DEGOS, L .
LANCET, 1989, 2 (8665) :746-747
[9]  
DESOIZE B, 1994, ANTICANCER RES, V14, P2291
[10]   SUPPRESSION OF APOPTOSIS ALLOWS DIFFERENTIATION AND DEVELOPMENT OF A MULTIPOTENT HEMATOPOIETIC-CELL LINE IN THE ABSENCE OF ADDED GROWTH-FACTORS [J].
FAIRBAIRN, LJ ;
COWLING, GJ ;
REIPERT, BM ;
DEXTER, TM .
CELL, 1993, 74 (05) :823-832